Антрациклины в лечении солидных опухолей у детей
DOI :
https://doi.org/10.15587/2313-8416.2015.41728Mots-clés :
антрациклины, доксорубицин, химиотерапия, кардиотоксичность, злокачественные опухоли у детейRésumé
Цель - анализ литературных данных по использованию антрациклинов в лечении солидных опухолей у детей.
Методы – обзор литературы, посвященной применению антрациклинов в лечении солидных опухолей у детей.
Результаты: большинство схем полихимиотерапии, которые используются в лечении солидных опухолей у детей, включают антрациклины, среди которых одним из наиболее востребованных оказался доксорубицин.
Выводы: назначение препарата ограничено,ввиду еговысокойкардиотоксичности.
Références
Gelperina, S. E., Shvets, V. I. (2009). Drug delivery systems based on polymeric nanoparticles. Biotechnology, 3, 8–23.
Dudnichenko, A. S., Krasnopolskiy, Y. M., Shvets, V. I. (2001). Liposomal drugs in experimental and clinical. Kharkov, PA Caravel, 143.
Dedkov, A. G., Boychuk, S. І., Yugrinov, O. G. et. al. (2012). Іndivіdualіzatsіya hіmіoterapії from ailments for osteosarcoma fallow od angіografіchnih kriterіїv forecast lіkuvalnogo pathomorphosis. Klіnіchna onkologіya, 7, 22–26.
Anokhin, A. N., Chushkin, M. I., Kolganov, A. V. (2011). Anthracycline cardiomyopathy. Terapevt. arhiv, 10, 72–76.
Yerenkov, V. A. (1984). A clinical examination of a child. Kiev, Health, 230.
Krasnopolskiy, Y. M., Shvets, V. I. (2013). Technological principles of production of liposomal drugs and their use in the clinic. Nanotechnology and Health, 2, 6–7.
Aliyev, M. D., Polyakov, V. G., Mentkevicha, G. L., Beacon, S. A. (Eds.) (2012). Pediatric Oncology. Moscow: Publishing. Group RCRC. Practical medicine, 684.
Lanzkowsky. P. (Ed.) (2011). Manual of Pediatric Hematology and Oncology (Fifth Edition). Elsevier Inc., 1027.
Dudnіchenko, O. S., Klimnyuk, G. І., Bіletsky, V. E. (2013). Pediatric onkology. Kharkiv, "facts", 400.
byPizzo, F. A., Poplack, D. G. (Eds.) (2011). Principles and practice of Pediatric Oncology. Lippincott-Raven/Williams & Wilkins, 2011 Lippincott, 1531.
Téléchargements
Publié-e
Numéro
Rubrique
Licence
(c) Tous droits réservés Владимир Евгеньевич Белецкий 2015
Cette œuvre est sous licence Creative Commons Attribution 4.0 International.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
